Please click here
to download the
pdf version of the G1D information available in this website

G1D - Glucose transporter type 1 deficiency syndrome

  1. G1D 101- An Introduction
  2. Treatment of G1D
  3. Common questions after the diagnosis of G1D
  4. G1D Research
  5. Movement disorders in G1D
  6. G1D Resources

About the Collaborators

The Child Brain Foundation:
The Child Brain Foundation is a 501 (c) 3 certified non-for-profit organization, based in Dallas, Texas. It supports research projects to understand and treat pediatric neurological disorders and encourages greater communication between scientists, professionals, families and the general public. For additional information, please visit www.childbrainfoundation.org.

About the author- Juan Pascual, M.D., Ph.D:
Dr. Juan M. Pascual holds appointments to the faculty of the Departments of Neurology and Neurotherapeutics, Pediatrics, and Physiology at The University of Texas Southwestern Medical Center and directs the Rare Brain Disorders Clinic and Laboratory, where he conducts research on the genetic and molecular basis of neurological and neuromuscular diseases of childhood. His research focuses on the molecules that regulate nerve and muscle excitability and communication, and has published and lectured extensively in this field. He specializes in diseases of the nervous and neuromuscular systems of infants, children and adults with a particular emphasis on complex diagnostic problems.

About the Sponsor, The National Institute of Health:
The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation's medical research agency—making important discoveries that improve health and save lives. The Collaboration, Education, and Test Translation (CETT) Program for Rare Genetic Diseases was developed by the NIH Office of Rare Diseases Research. The goals were to promote new test development for rare genetic diseases, to facilitate the translation of genetic tests from research laboratories to clinical practice, to establish collaborations and provide education about each rare genetic diseases, to stimulate related genetic research, to enhance the clinical impact of testing, and to support the collection and storage of genetic test result information in publicly accessible databases to leverage the information into new research and new treatment possibilities